Tumor-Inhibiting Basidiomycetes. Isolation and Cultivation in the Laboratory

Marlin A. Espenshade, Evan W. Griffith

Mycologia · 1966 · 14 citations · 0 references

Concepts

Abstract

SUMMARYIn a primary screening for antitumor agents under government contract, using fermentation products from basidiomycetous fungi, almost 1% of the samples yielded an acceptable titer for confirmation studies and further purification and characterization. The activities were spread through many genera and families and were not specific to a particular group of organisms (Table II). With the exceptions of B 194931 (Tricholoma panaeolum), which was active against the mouse transplantable tumor Carcinoma 755, and B 191696 (Lentinus lepideus) and B 195681 (Merulius niveus), which were active against both mouse transplantable tumors Carcinoma 755 and Sarcoma 180, all the Accepts were positive against Sarcoma 180. Fairly simple medium formulations (Table I) can be used for most of the genera studied in this primary screening program.